Sachiaki Ibe
Directeur Général chez ZERIA PHARMACEUTICAL CO., LTD.
Fortune : 21 M $ au 30/04/2024
Postes actifs de Sachiaki Ibe
Sociétés | Poste | Début | Fin |
---|---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Président | 27/06/2014 | - |
Directeur Général | 27/06/2014 | - | |
Directeur/Membre du Conseil | 01/03/1972 | 01/06/2014 | |
President | 01/04/1982 | 01/06/2014 | |
Sales & Marketing | 01/11/1994 | 01/03/1996 | |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Président | 05/07/2011 | - |
Historique de carrière de Sachiaki Ibe
Statistiques
Internationale
Japon | 2 |
Suisse | 2 |
Opérationnelle
Chairman | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
Entreprise privées | 1 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
- Bourse
- Insiders
- Sachiaki Ibe
- Expérience